Skip to main content
. 2024 Feb 16;41(4):1512–1525. doi: 10.1007/s12325-024-02802-3

Table 1.

Qualitative AD study: adult and adolescent demographic and clinical characteristics

Adults (n = 15) Adolescents (n = 6)
Age (in years)
 Mean (SD) 30.4 (12.9) 13.0 (1.0)
 Min–max (years) 19–64 12–15
Gender, n (%)
 Female 11 (73%) 3 (50%)
Race, n (%)
 Asian 8 (53%) 5 (83%)
 Black 0 (0%) 1 (17%)
 Native Hawaiian/Pacific Islander 1 (7%) 0 (0%)
 White 4 (27%) 0 (0%)
 Biracial 1 (7%) 0 (0%)
 Missing 1 (7%) 0 (0%)
Ethnicity, n (%)
 Non-Hispanic/non-Latino 13 (87%) 6 (100%)
Education level, n (%)
 Elementary/primary school 0 (0%) 3 (50%)
 Some high school 0 (0%) 3 (50%)
 Some college 5 (33%) 0 (0%)
 Associate degree 1 (7%) 0 (0%)
 Bachelor’s degree 7 (47%) 0 (0%)
 Post-graduate 1 (7%) 0 (0%)
 Trade 1 (7%) 0 (0%)
Time since first symptom, n (%)
 1–5 years 4 (27%) 3 (50%)
 6–10 years 11 (73%) 3 (50%)
Time since diagnosis, n (%)
 Less than 1 year 1 (7%) 0 (0%)
 1–5 years 6 (40%) 3 (50%)
 6–10 years 8 (53%) 3 (50%)
Medications, n (%)a
 Triamcinolone 3 (20%) 1 (17%)
 Hydrocortisone 2 (13%) 1 (17%)
 Tacrolimus 3 (20%) 0 (0%)
 Crisaborole 4 (27%) 2 (34%)
 Halobetasol 1 (7%) 0 (0%)
 Over the counter 5 (33%) 2 (34%)
 None 2 (13%) 1 (17%)
Overall health, n (%)
 Fair 3 (20%) 2 (34%)
 Good 4 (27%) 3 (50%)
 Very good 5 (33%) 1 (17%)
 Excellent 2 (13%) 0 (0%)

aDoes not sum to 100% as participants could report multiple medications